Natera Raises FY21 Sales Outlook After Mixed Q3 earnings

Natera Inc NTRA posted Q3 sales of $158.1 million, +61% Y/Y, beating the consensus of $151.36 million, driven by an increase in test volume and product revenues.
Product revenues rose 62% to $150.7 million. Licensing and other revenues rose 53% to $7.5 million.
Natera processed approximately 407,300 tests in Q3, a 55% increase from Q3 2020.
The firm's Q3 EPS loss widened to $(1.63) from $(0.72) a year ago and missing the consensus of $(1.27).
The company ended the quarter with $95.1 million in cash and cash equivalents and $928.6 million in short-term investments.
Guidance: Natera raised its FY21 revenue forecast to $615 million - $625 million, up from its previous forecast of $600 million - $620 million for the year. Analysts, on average, expect revenues of $614.7 million for 2021.
Price Action: NTRA shares closed up 4.92% at $116.12 on Friday.

Earnings Calendar